Catheter Introducer Sheaths Market

The market for Catheter Introducer Sheaths was estimated at $1.5 billion in 2025; it is anticipated to increase to $2.2 billion by 2030, with projections indicating growth to around $3.2 billion by 2035.

Report ID:DS1801044

Author:Debadatta Patel - Senior Consultant

Published Date:January 2025

Datatree

Life Science

Medical Device

Catheter Introducer Sheaths

Customization Available

Catheter Introducer Sheaths - 2025-2035

Market Outlook
Market Key Insights
Growth Opportunity
Market Dynamics
Application
Recent Development
Impact Analysis

Report Summary

Market Data

Methodology

Table of Contents

Report Summary

Market Data

Methodology

Table of Contents

Global Catheter Introducer Sheaths Market Outlook

Revenue, 2025

$1.5B

Forecast, 2035

$3.2B

CAGR, 2026 - 2035

7.8%

The Catheter Introducer Sheaths industry revenue is expected to be around $1.5 billion in 2026 and expected to showcase growth with 7.8% CAGR between 2026 and 2035. The increasing use of catheter introducer sheaths reflects their vital role in modern interventional medicine, which is being driven by the growing demand for invasive vascular procedures, by the increasing use of image guided endovascular treatments and by the prevalence of cardiovascular and peripheral vascular disease in the elderly. With the emphasis on radial access and outpatient catheter based procedures, the demand for high quality introducer sheaths has increased. This is because such introducer sheaths reduce access site complications and help streamline procedure workflow which in turn improves patient care. The dominant product line is the coated catheter introducer sheaths which generated sales of $0.98 billion in the year 2025. These catheter introducer sheaths have a low friction surface and are hemocompatible. Cardiology along with interventional radiology makes up 66% of the catheter introducer sheath applications, making them central to the hospitals, cath labs and interventional suites market.

Interventional cardiology catheter introducers are sterile, sheathed tubes which permit controlled catheter positioning and exchange within the vascular system. Key features of these devices include kink resistant shafts, radiopaque markers and integral hemostatic valves. They also have a hydrophilic coating which reduces the risk of injury to the blood vessels. With this technology, interventional radiologists are able to undertake various procedures including peripheral angioplasty and stenting, electrophysiology and cardiology interventions and interventional structural heart work. They are also utilised in the fields of endovascular aneurysm repair, thrombectomy and embolisation. These medical tools help in minimally invasive surgeries and complex endovascular interventions. Growing demand is fuelled by trends such as the shrinking size of French gauge catheters, the growing popularity of radial access techniques and other catheter placement methods, and innovations in catheter coatings which improve compatibility with the body. Furthermore, catheter introducer sheaths are now being included in vascular access systems, resulting in procedures being more efficient and thus raising demand at hospitals that carry out a lot of cardiac and vascular interventions.

Catheter Introducer Sheaths market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035 — Catheter Introducer Sheaths Market Outlook

Market Key Insights

The Catheter Introducer Sheaths market is projected to grow from $1.5 billion in 2025 to $3.2 billion in 2035. This represents a CAGR of 7.8%, reflecting rising demand across Cardiovascular Interventions, Electrophysiology Procedures, and Interventional Radiology.
This market is dominated by the key players such as Merit Medical, Terumo Corporation and Medtronic which determine the competitive landscape.
The North American region is the current market leader in the catheter introducer sheaths market, and it is anticipated that it will keep growing at a rate between 5.1 and 7.5% annually from 2025 to 2030.
The highest growth rates are expected to occur in emerging markets such as India, Thailand and China, at compound annual growth rates of between 9 10.8% .
By 2030, the catheter introducer sheaths market will be boosted by technological advancements in product design worth $178 million.
Between 2025 and 2035, the catheter introducer sheaths industry is expected to reach $1.7 billion in value. The major applications are in electrophysiology and interventional radiology where a considerable rise in the market share is predicted.
With
rising prevalence of cardiovascular diseases combined with increased adoption of minimally invasive procedures, and
Technological Advancements in Sheath Design Enhancing Procedure Efficiency and Safety, Catheter Introducer Sheaths market to expand 112% between 2025 and 2035.

Catheter Introducer Sheaths - Country Share Analysis

Opportunities in the Catheter Introducer Sheaths

A growing number of U.S. and Canadian cardiac catheterisation labs are choosing coated catheter introducer sheaths to carry out more complicated procedures with catheters inserted into a patients blood vessels and to reduce catheter complications. There is also still a considerable untapped market for hydrophilic and haemostatic valves in hospitals and ambulatory surgical centres. In coated catheter introducer sheaths the predicted growth rate up to 2030 is from $0.98 billion to $1.47 billion. The most significant growth in this market will be seen in the region of interventional cardiology and structural heart devices.

Growth Opportunities in North America and Asia-Pacific

There are several region's where vascular access devices are in high demand in North America. They are predominantly used in medical procedures such as cardiology and electrophysiology. Cath labs that provide day time treatment are mainly in need of thin walled, large bore sheaths. These sheaths require less friction and they are also designed to stop bleeding. In the present, the industry is very competitive. Multinational corporations have large product lines and contracts with purchasing groups, which makes the field highly standardised. There are still opportunities in the market for introducer sheaths that have unique characteristics. These products must reduce the risk of vascular complications, decrease the time needed for procedures and work with other devices used during interventions in cardiology, such as closure systems. The region has a significant cardiovascular disease problem and there is a quick move to minimally invasive treatments. The region is also experiencing a move away from femoral access and towards radial access. There is an increase in the number of out patient surgical centres performing endovascular procedures. Strict clinical guidelines are in place, which supports the use of catheter introducer sheaths which are proven to be safe and compatible with other products from different companies.

There is growing demand in the Asia Pacific region for catheter introducer sheaths in cardiology and interventional radiology. Neurology and neurovascular interventions, meanwhile, are gaining momentum as profitable region's of business. As a result, hospitals are in need of cost effective introducer sheaths designed for specific procedures that are also reliable. There is demand for such products from stroke, oncology and vascular treatment services. The vascular access market is highly competitive, with a combination of international corporations and local manufacturers, resulting in intense competition due to hospital purchasing departments price sensitivity and government purchasing procedures. This competitive market presents opportunities for the development of products tailored to regional needs. These tailored products often feature simplified designs and user training. Healthcare expenditure increases in the region, along with the installed base of cath labs and hybrid operating rooms, backed by government investment in infrastructure for stroke and cardiovascular disease. As a result, awareness of catheter procedures among clinicians and patients has grown. There is also a preference for minimally invasive procedures rather than traditional surgery and this trend increases the demand for catheter introducers.

Market Dynamics and Supply Chain

Driver: Rising Prevalence of Cardiovascular Diseases Combined With Increased Adoption of Minimally Invasive Procedures

The catheter introducer sheaths market is also being driven by the growing prevalence of cardiovascular diseases (CVD) worldwide, which increases demand for interventional procedures such as angioplasty, stenting, and structural heart treatments that require reliable vascular access. Aging populations, lifestyle factors, and rising chronic conditions like hypertension and diabetes are also expanding the pool of patients needing cardiovascular interventions. At the same time, there is also an industry‑wide shift toward minimally invasive procedures across cardiology, electrophysiology, and interventional radiology. These techniques reduce hospital stays, lower complication risks, and support faster recovery compared to traditional open surgeries. Catheter introducer sheaths are also essential for enabling safe access and device delivery in such procedures, which has also increased their utilization in catheterization laboratories and hybrid OR suites. Combined, the surge in CVD cases and procedural preference for less invasive surgical approaches are also significantly boosting market demand and driving innovation in sheath design and performance.

A key driver of market growth is also continuous technological innovation in catheter introducer sheaths, including hydrophilic coatings, low‑profile materials, hemostatic valve integration, and steerable tip technologies. Hydrophilic coatings reduce friction for smoother insertion and withdrawal, lowering vascular trauma and improving patient comfort. Integrated hemostatic valves help maintain blood control during device exchanges, reducing the need for manual intervention and enhancing operating room efficiency. Steerable and torqueable sheath designs improve maneuverability through complex anatomy, supporting precision in electrophysiology and interventional radiology procedures. These advancements increase procedural success rates, foster clinician preference, and support wider adoption of introducer sheaths across a range of minimally invasive interventions.

Restraint: High Costs of Advanced Sheath Technologies Limiting Adoption in Cost‑Conscious Settings

Innovative catheter introducer sheaths featuring hydrophilic coatings, steerable tips, and hemostatic valves come at premium prices that can deter budget‑constrained hospitals and outpatient facilities. Many smaller clinics opt for basic sheaths or reusable alternatives to manage costs, which depresses sales of higher‑margin advanced products. This pricing barrier slows market penetration in emerging regions and limits overall revenue growth for manufacturers, especially where reimbursement policies do not adequately cover device upgrades.

Opportunity: Expanding utilization of Catheter Introducer Sheaths in neurovascular interventions within rapidly modernizing Asian healthcare systems and Increasing adoption of affordable non-coated Catheter Introducer Sheaths in resource-constrained public hospitals across Latin America

There is a significant increase in the number of strokes in Asian countries where healthcare is developing. As a result, investment is being made in hospitals with the facilities to deal with the complications of a stroke. There is a strong need for catheter introducer sheaths specifically designed for use in delicate cerebral vessels. These would include ultra low profile introducer sheaths that have a special coating. This reduces access trauma and the risk of the blood clotting. Low penetration of the technology outside major urban hospitals means that smaller cities have substantial under utilisation of the service. In China, India and rapidly expanding economies in South East Asia, collaborations between local distributors and government backed initiatives will be the drivers of growth in coated neurovascular catheter introducer sheaths.

Across the public hospitals in Latin America, budgetary restrictions together with the disparities in the reimbursement mean that the non coated catheter introducer sheaths are chosen because they give reliable results at reduced costs. There is considerable unfulfilled demand from catheterization laboratories for vascular access devices that are not only competitively priced but also locally available and distributed. By 2030 the non coated market is expected to be worth 0.73 billion dollars, an increase from 0.53 billion dollars, expanding at a CAGR of 6.46%. The region with the highest rate of volume increase is in Latin America where the growth is in interventional cardiology and peripheral angioplasty.

Challenge: Risk of Complications and Lack of Standardized Training Affecting Clinician Confidence

Complications such as vascular trauma, bleeding, or infection associated with improper sheath use can reduce clinician confidence and hinder wider adoption. Additionally, there is variability in training and proficiency across hospitals, particularly in electrophysiology and interventional radiology suites, which leads some practitioners to favor familiar, simpler access tools. This variability in use and outcomes dampens demand for newer sheath technologies and impacts overall market expansion.

Supply Chain Landscape

Medical-grade Polymer Materials

DuPontBASFCovestro

Vascular Component Extrusion

Zeus Industrial ProductsPutnam PlasticsRaumedic

Catheter Introducer Sheaths

Terumo CorporationMedtronicMerit Medical

Interventional Cardiology Centers

HospitalsInterventional cardiology labsAmbulatory surgical centers

Medical-grade Polymer Materials

DuPontBASFCovestro

Vascular Component Extrusion

Zeus Industrial ProductsPutnam PlasticsRaumedic

Catheter Introducer Sheaths

Terumo CorporationMedtronicMerit Medical

Interventional Cardiology Centers

HospitalsInterventional cardiology labsAmbulatory surgical centers

Catheter Introducer Sheaths - Supply Chain

Use Cases of Catheter Introducer Sheaths in Cardiovascular Interventions & Interventional Radiology

Cardiovascular Interventions : In cardiovascular interventions such as angioplasty, percutaneous coronary intervention (PCI), and structural heart procedures, catheter introducer sheaths provide essential vascular access for guidewires, catheters, and therapeutic devices to enter the coronary arteries and heart chambers. Integrated, hydrophilic‑coated introducer sheaths designed for radial and femoral access are widely used because they minimize vascular trauma, reduce procedural time, and improve patient safety. This application is the largest segment of the catheter introducer sheaths market, driven by the rising prevalence of cardiovascular diseases and expanded use of minimally invasive procedures in hospital cath labs and outpatient suites. Prominent players supplying these sheaths include Terumo Corporation, Medtronic, Boston Scientific, Abbott Laboratories, and B. Braun, whose broad portfolios and innovations in low‑profile materials and kink resistance enhance procedural success and clinician adoption.

Electrophysiology Procedures : In electrophysiology procedures like cardiac ablation and arrhythmia mapping, introducer sheaths serve as critical conduits for electrophysiology catheters and mapping tools to access the heart’s electrical pathways. Specialty steerable and valved introducer sheaths with enhanced torque control and hemostatic valves are predominantly used to navigate tortuous anatomy and maintain hemostasis during prolonged procedures. This application benefits significantly from advanced sheath designs that improve maneuverability and reduce access‑site complications, making them indispensable in EP labs. Leading manufacturers such as Terumo Corporation, Teleflex, Boston Scientific, and Merit Medical Systems provide tailored sheath solutions with features like hydrophilic coatings, radiopaque markers, and optimized lumen sizes, supporting high procedure volumes and complex electrophysiological interventions.

Interventional Radiology : In interventional radiology, catheter introducer sheaths are used to gain vascular access for diagnostic imaging and therapeutic procedures such as embolization, biopsies, and targeted drug delivery. Sheaths with radiopaque markers and smooth dilators facilitate precise positioning under imaging guidance while reducing vascular trauma and procedural time. Due to increasing demand for minimally invasive treatments across radiology suites, these sheaths are vital for enabling stable access points and efficient device exchanges. Cook Medical, Terumo Corporation, Boston Scientific, and Abbott Laboratories are key suppliers offering radiology‑focused sheath products with kink resistance and enhanced maneuverability that enhance clinician confidence and procedural success rates.

Recent Developments

Recent developments in catheter introducer sheaths reflect strong growth as aging demographics and rising cardiovascular interventions boost demand. A key trend is the shift toward minimally invasive procedures and enhanced vascular access technologies that improve patient outcomes and reduce hospital stays. Increased healthcare utilization for chronic heart and bladder conditions has accelerated adoption across hospitals and ambulatory surgical centers. Manufacturers are innovating with integrated hemostasis valves, ergonomic designs, and advanced materials to support broader procedural versatility and safety.

August 2025 : Merit Medical Systems launches the Prelude Wave Hydrophilic Sheath Introducer featuring SnapFix securement technology in the U.S., designed to improve radial access performance and reduce arterial spasm and occlusion during procedures.

June 2023 : Merit Medical completed strategic portfolio expansion by acquiring AngioDynamics’ dialysis catheter line and the Surfacer Inside‑Out access catheter solution from Bluegrass Vascular Technologies, indirectly strengthening its vascular access offerings.

February 2023 : Abbott disclosed a definitive agreement to acquire Cardiovascular Systems, Inc. (CSI), broadening its vascular treatment capabilities — a strategic move relevant to cardiovascular device access and sheath‑dependent procedures.

Impact of Industry Transitions on the Catheter Introducer Sheaths Market

As a core segment of the Medical Device industry, the Catheter Introducer Sheaths market develops in line with broader industry shifts. Over recent years, transitions such as Technological Advancements in Product Design and Rise in Geriatric Population and Associated Health Disorders have redefined priorities across the Medical Device sector, influencing how the Catheter Introducer Sheaths market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

Technological Advancements in Product Design

Advances in technology are driving the Catheter Introducer Sheaths industry forward, with several technological developments expected to boost sales by approximately $178 million by the year 2030. These technological improvements include miniaturisation of devices, bio compatible materials and improved infection control. As the size of introducer sheaths for vascular access become smaller and more MR compatible, companies are being forced to reassess their product lines to meet the demands of interventional cardiology, neurovascular procedures and other minimally invasive interventions. In addition to enhancing the clinical outcomes and procedural safety, the trend is also focusing on the competitive advantages related to the performance of sheaths, radial access, and compatibility with imaging technology. Companies are starting to use technology based product improvements as a main tool for increasing sales to high end consumers and for quickening the catheter introducer sheaths industry's rate of growth.

Rise in Geriatric Population and Associated Health Disorders

The global rise in the geriatric population has significantly influenced the demand for catheter introducer sheaths, driven by the increasing prevalence of cardiovascular and urinary disorders among older adults. Aging-related conditions such as chronic heart failure, arrhythmias, and bladder dysfunctions have necessitated frequent minimally invasive interventions, making catheter-based procedures more common. For instance, hospitals and cardiac care units are seeing higher utilization of introducer sheaths in procedures like angioplasty and cardiac catheterization, while urology departments increasingly rely on them for urinary catheter placements. This demographic-driven transition not only boosts demand for catheter sheaths but also impacts adjacent industries, including cardiovascular device manufacturing, surgical disposables, and hospital consumables, creating opportunities for integrated device solutions and specialized procedural kits.